{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:52:37Z","timestamp":1790743957457,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011723","name":"Myeloma UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clml.2021.04.013","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T11:39:07Z","timestamp":1619264347000},"page":"667-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial"],"prefix":"10.1016","volume":"21","author":[{"given":"Sarah","family":"Bird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Pawlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.04.013_bib0001","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2141.2002.03750.x","article-title":"Sex ratios and the risks of haematological malignancies","volume":"118","author":"Cartwright","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.04.013_bib0002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/eurpub\/ckq099","article-title":"Do women with cancer have better survival as compared to men after adjusting for staging distribution?","volume":"21","author":"Oberaigner","year":"2011","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.clml.2021.04.013_bib0003","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","article-title":"Sex disparities in cancer mortality and survival","volume":"20","author":"Cook","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clml.2021.04.013_bib0004","series-title":"Myeloma statistics","year":"2019"},{"key":"10.1016\/j.clml.2021.04.013_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4062\/biomolther.2018.103","article-title":"Sex differences in cancer: epidemiology, genetics and therapy","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.clml.2021.04.013_bib0006","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/ehm.12.51","article-title":"Understanding the molecular biology of myeloma and its therapeutic implications","volume":"5","author":"Boyd","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.clml.2021.04.013_bib0007","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/leu.2011.204","article-title":"A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial","volume":"26","author":"Boyd","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.04.013_bib0008","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1055-9965.EPI-11-0157","article-title":"Gender disparities in the tumor genetics and clinical outcome of multiple myeloma","volume":"20","author":"Boyd","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clml.2021.04.013_bib0009","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1158\/1078-0432.CCR-12-3211","article-title":"Long-term follow-up of MRC Myeloma IX trial: survival outcomes with bisphosphonate and thalidomide treatment","volume":"19","author":"Morgan","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2021.04.013_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(18)30687-9","article-title":"Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Jackson","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2021.04.013_bib0011","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.04.013_bib0012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.blre.2013.12.003","article-title":"The sex difference in haemoglobin levels in adults - mechanisms, causes, and consequences","volume":"28","author":"Murphy","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.clml.2021.04.013_bib0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.1977.tb06847.x","article-title":"A sex difference in the platelet count","volume":"37","author":"Stevens","year":"1977","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.04.013_bib0014","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00424-007-0308-1","article-title":"Gender differences in kidney function","volume":"455","author":"Saboli\u0107","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.clml.2021.04.013_bib0015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.canep.2015.10.020","article-title":"Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: evidence from US population data","volume":"39","author":"Hossain","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clml.2021.04.013_bib0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4081\/hr.2013.e4","article-title":"Male-to-female sex ratios of abnormalities detected by fluorescence in situ hybridization in a population of chronic lymphocytic leukemia patients","volume":"5","author":"Cant\u00fa","year":"2013","journal-title":"Hematol Rep"},{"key":"10.1016\/j.clml.2021.04.013_bib0017","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2012-12-471888","article-title":"Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells","volume":"121","author":"Walker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.04.013_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800267-4.00001-8","article-title":"Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair","volume":"122","author":"Matthews","year":"2014","journal-title":"Adv Immunol"},{"key":"10.1016\/j.clml.2021.04.013_bib0019","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/2319-4170.128734","article-title":"Biological function of activation-induced cytidine deaminase (AID)","volume":"37","author":"Kumar","year":"2014","journal-title":"Biomed J"},{"key":"10.1016\/j.clml.2021.04.013_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000478265","article-title":"Gender-specific aspects in patients with multiple myeloma undergoing autologous stem cell transplantation: a single-center experience","volume":"93","author":"Posch","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.clml.2021.04.013_bib0021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-018-0102-7","article-title":"Disease and outcome disparities in multiple myeloma: exploring the role of race\/ethnicity in the Cooperative Group clinical trials","volume":"8","author":"Ailawadhi","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2021.04.013_bib0022","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/bjh.17237","article-title":"Sex differences in outcomes in multiple myeloma","volume":"192","author":"Derman","year":"2021","journal-title":"Br J Haematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021001579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021001579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:38:05Z","timestamp":1761871085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021001579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2152265021001579"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.04.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}